Tonix Pharmaceuticals Holding (TNXP): AQR Capital Management, LLC cut its TNXP stake below 5% (3.9%) 3.9%
AQR Capital Management, LLC cut its TNXP stake below 5% (3.9%).
- 3.9%
- Stake
- 671K
- Shares owned
- Stake as of
- Sep 30, 2026
- Filed
- Nov 13, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Aug 10, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 18, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On August 18, 2026, the Board of Directors of Tonix Pharmaceuticals Holding Corp. (the “Company”) appointed Dr. Seth Lederman, the Company’s President and Chief Executive Officer, as the Company’s Interim Chief Medical Officer.”
What came next
- Oct 15, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
- Nov 9, 2026Company filing · Form 8-K · ResultsReported its results
- Nov 11, 2026Insider · First insider buy since Aug 2025CEO purchased ~$20K of TNXP shares in the open market
- Nov 13, 20265% stakeAQR Capital Management, LLC reported a passive stake (13G) of 3.9%
How to read SEC Schedule 13G
A Schedule 13D and a Schedule 13G both disclose beneficial ownership of more than 5% of a US company's voting shares. A 13D is the long form, filed by holders who may seek to influence or control the company, and it must state what they intend to do. A 13G is the short form, open only to passive holders and to certain institutions holding in the ordinary course of business, and it asks no question about intent.
Full guide: Schedule 13D vs Schedule 13G: what is the difference?
What else is on file for Tonix Pharmaceuticals Holding
For Tonix Pharmaceuticals Holding, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TNXP page.
How this filing works
Explore the data
Other disclosures at Tonix Pharmaceuticals Holding
Everything OQRO holds on this company is on its TNXP page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data